316 related articles for article (PubMed ID: 23592524)
41. [Analogs of somatostatin and carcinoid tumors].
Gutiérrez Rodero F; Morales Cano JM; de Blas Laborda C; González Barber A
Med Clin (Barc); 1990 Jun; 95(2):78-9. PubMed ID: 2250512
[No Abstract] [Full Text] [Related]
42. Hepatic artery embolization for control of symptoms, octreotide requirements, and tumor progression in metastatic carcinoid tumors.
Schell SR; Camp ER; Caridi JG; Hawkins IF
J Gastrointest Surg; 2002; 6(5):664-70. PubMed ID: 12399054
[TBL] [Abstract][Full Text] [Related]
43. [Current treatment of carcinoid tumor].
Elizalde I; Borda F
Gastroenterol Hepatol; 2002 Oct; 25(8):508-13. PubMed ID: 12361534
[No Abstract] [Full Text] [Related]
44. A pressing situation.
Scialla JJ; Hemnes AR
Am J Med; 2005 Dec; 118(12):1347-9. PubMed ID: 16378775
[No Abstract] [Full Text] [Related]
45. Comparison of Octreotide and Vasopressors as First-Line Treatment for Intraoperative Carcinoid Crisis.
McCully BH; Kozuma K; Pommier S; Pommier RF
Ann Surg Oncol; 2024 May; 31(5):2996-3002. PubMed ID: 38227166
[TBL] [Abstract][Full Text] [Related]
46. Serum chromogranin A reflects regression of metastatic carcinoid during prolonged octreotide treatment.
Pregun I; Gergics P; Dabasi G; Igaz P; Racz K; Tulassay Z
Eur J Gastroenterol Hepatol; 2009 Apr; 21(4):476-7. PubMed ID: 19382304
[No Abstract] [Full Text] [Related]
47. Carcinoid crisis and reversible right ventricular dysfunction after embolization in untreated carcinoid syndrome.
Majeed F; Porter TR; Tarantolo S; Duhachek-Stapelman A; Xie F; Elhendy A
Eur J Echocardiogr; 2007 Oct; 8(5):386-9. PubMed ID: 17011239
[TBL] [Abstract][Full Text] [Related]
48. Surgical treatment of advanced-stage carcinoid tumors: lessons learned.
Boudreaux JP; Putty B; Frey DJ; Woltering E; Anthony L; Daly I; Ramcharan T; Lopera J; Castaneda W
Ann Surg; 2005 Jun; 241(6):839-45; discussion 845-6. PubMed ID: 15912033
[TBL] [Abstract][Full Text] [Related]
49. Gastrointestinal carcinoid tumors: diagnosis and treatment.
Stamatakos M; Kontzoglou K; Sargedi C; Tsaknaki S; Iannescu R; Safioleas C; Kaitanidi V; Safioleas M
Chirurgia (Bucur); 2010; 105(6):759-66. PubMed ID: 21351698
[TBL] [Abstract][Full Text] [Related]
50. Predicting therapeutic response and degree of pituitary tumour shrinkage during treatment of acromegaly with octreotide LAR.
Jenkins PJ; Emery M; Howling SJ; Evanson J; Besser GM; Monson JP
Horm Res; 2004; 62(5):227-32. PubMed ID: 15477693
[TBL] [Abstract][Full Text] [Related]
51. Octreotide in the prevention of intra-abdominal complications following elective pancreatic resection: a prospective, multicenter randomized controlled trial.
Suc B; Msika S; Piccinini M; Fourtanier G; Hay JM; Flamant Y; Fingerhut A; Fagniez PL; Chipponi J;
Arch Surg; 2004 Mar; 139(3):288-94; discussion 295. PubMed ID: 15006886
[TBL] [Abstract][Full Text] [Related]
52. Treatment of gastroenteropancreatic neuroendocrine tumours with octreotide LAR.
Tomassetti P; Migliori M; Corinaldesi R; Gullo L
Aliment Pharmacol Ther; 2000 May; 14(5):557-60. PubMed ID: 10792118
[TBL] [Abstract][Full Text] [Related]
53. Radiofrequency ablation treatment of refractory carcinoid hepatic metastases.
Wessels FJ; Schell SR
J Surg Res; 2001 Jan; 95(1):8-12. PubMed ID: 11120628
[TBL] [Abstract][Full Text] [Related]
54. Treatment of metastatic carcinoid tumours with octreotide.
Ozbey N
Int J Clin Pract; 2002 Jun; 56(5):407. PubMed ID: 12137455
[No Abstract] [Full Text] [Related]
55. Multimodality treatment for gastric carcinoid tumor with liver metastases.
Caplin ME; Hodgson HJ; Dhillon AP; Begent R; Buscombe J; Dick R; Rolles K; Burroughs AK
Am J Gastroenterol; 1998 Oct; 93(10):1945-8. PubMed ID: 9772061
[TBL] [Abstract][Full Text] [Related]
56. Octreotide treatment of carcinoid hypertensive crisis.
Warner RR; Mani S; Profeta J; Grunstein E
Mt Sinai J Med; 1994 Sep; 61(4):349-55. PubMed ID: 7969229
[TBL] [Abstract][Full Text] [Related]
57. [Management of digestive system carcinoid tumors and carcinoid syndrome].
Mondragón Sánchez RJ; Castillero Pinilla C; Saldívar Moreno C; Oñate Ocaña LF; Ruiz Molina JM; Aiello Crocifoglio V
Rev Gastroenterol Mex; 1998; 63(4):204-10. PubMed ID: 10319670
[TBL] [Abstract][Full Text] [Related]
58. [Management of intraoperative carcinoid crises].
Dralle H
Chirurg; 2016 Jul; 87(7):610. PubMed ID: 27251478
[No Abstract] [Full Text] [Related]
59. [Update on the anesthetic management of patients with malignant carcinoid syndrome].
Rodríguez-Cosmen C; Trillo Urrutia L; Pacreu Terradas S; Comps Vicente O; Escolano Villén F
Rev Esp Anestesiol Reanim; 2005 May; 52(5):291-4. PubMed ID: 15968907
[TBL] [Abstract][Full Text] [Related]
60. Octreotide and ketoconazole for persistent ectopic ACTH Cushing's disease due to mediastinal carcinoid.
Parthiban A; Sundaram DS; Reddy DJ; Girinath MR; Prabhakaran R; Chidambaranathan N
J Assoc Physicians India; 1995 Feb; 43(2):140. PubMed ID: 9282686
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
